Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06512168 · ClinicalTrials.gov registry record · NA
Measuring Aided Language Development
A NA study of Cerebral Palsy and Down Syndrome, sponsored by University of Central Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06512168: Recruiting NA study of Cerebral Palsy and Down Syndrome, sponsored by University of Central Florida.
NCT06512168 is a NA study of Cerebral Palsy and Down Syndrome that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 60 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06512168, a NA study of Cerebral Palsy and Down Syndrome, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
Primary Outcome
Aided AAC Sentence Length Measured in Morphemes
Conditions Studied
Interventions
- BEHAVIORAL AAC Generative Language Intervention
Study Locations (1)
Florida
- University of Central Florida - Innovative Center - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06512168 shows while recruiting
NCT06512168 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (74% lower).
The record links to 6 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which AAC Generative Language Intervention is the first listed.
NCT06512168 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06512168 about?
NCT06512168 is a clinical study titled "Measuring Aided Language Development". The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
What is the current status of trial NCT06512168?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-04-01. Estimated completion is 2028-03-31.
What conditions does trial NCT06512168 study?
This clinical trial studies the following conditions: Cerebral Palsy, Down Syndrome, Speech Sound Disorder, Apraxia of Speech, Speech and Language Disorder.
What interventions are being tested in trial NCT06512168?
The interventions under investigation include: AAC Generative Language Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06512168?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06512168 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06512168's enrollment target sits among peer trials
60 36th of 91 higher than 54 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Neuromodulation of the Cortex and Spinal Cord
RECRUITING · NA
-
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI